Related Posts
Plan stronger CKDu research with the new ISN i3C Toolkit
What if better research approaches could help take the “unknown” out of chronic kidney disease... read more
Explore WCN’26 late-breaking trials with NephJC and Kidney International Reports®
NephJC has extended the conversation around WCN’26 late-breaking trials with expert commentary... read more
ISN Journal summaries on parathyroid hormone in CKD-related osteoporosis and kidney care fragility in Nepal
Kidney International® Uremia and parathyroid hormone have distinct effects on bone protein... read more
ISN Journal summaries: effect of pravastatin on ADPKD and 10 years of Kidney International Reports®
Kidney International® A randomized controlled trial evaluated the effect of pravastatin on... read more
Taking the unknown out of CKDu: Read the new report from ISN i3C in Kidney International®
After two decades of research, the causes of chronic kidney disease of undetermined... read more
ISN Journal summaries on pediatric CKD outcomes and homelessness as a social determinant of kidney health
Kidney International® Establishing a core outcome measure for life participation in children... read more
Bridging global kidney care gaps through data: KI presents ISN-GKHA Interactive Map
A recent Kidney International® editorial showcases the ISN-Global Kidney Health Atlas (ISN-GKHA) Interactive Map, an open-access tool... read more
“Stay on top of the evidence base” — Adeera Levin on WCN’26 HIT sessions
At WCN’26, the high-impact trials (HIT) and late-breaking clinical trials (LBCT) sessions will show you what matters most for patient... read more
Research in action: How ISN committees are driving the future of kidney research — and how you can be part of it
Across the ISN’s research groups and committees, this year has been... read more
Rethinking kidney trials: The ISN’s PARADIGM roadmap moves into action
Kidney disease research is entering a pivotal moment. Kidney International® published... read more
